Lacrimal Duct Obstruction

Download PDF

Recent Publications on Lacrimal Duct Obstruction:
Success rate and cause of failure for late probing for congenital nasolacrimal duct obstruction. PURPOSE: To evaluate the outcome of late probing for congenital...	24th June, 2008	Orbit, Lacrimal & Ophthalmic plastic service, Shri Ganapati Netralaya,	J Pediatr Ophthalmol Strabismus. 2008 May-Jun;45(3):168-71.
Late probing success for congenital nasolacrimal duct obstruction. PURPOSE: To evaluate the outcome of late probing for congenital...	24th June, 2008		J Pediatr Ophthalmol Strabismus. 2008 May-Jun;45(3):138.
Re: "transcanalicular dacryocystorhinostomy with diode laser: long-term results". PURPOSE: To evaluate the outcome of late probing for congenital...	20th June, 2008		Ophthal Plast Reconstr Surg. 2008 May-Jun;24(3):245; author reply 245. DOI Direct Link
Topical antiglaucoma medications and lacrimal drainage system obstruction. PURPOSE: To evaluate the effect of topical antiglaucoma medications on the...	20th June, 2008	Eye Research Center, Rassoul Akram Hospital, Iran University of Medical	Ophthal Plast Reconstr Surg. 2008 May-Jun;24(3):172-5. DOI Direct Link
Effect of short-duration silicone intubation in congenital nasolacrimal duct obstruction. PURPOSE: To determine the incidence of premature dislocation of silicone...	20th June, 2008	Wake Forest University Eye Center, Wake Forest University School of	Ophthal Plast Reconstr Surg. 2008 May-Jun;24(3):167-71. DOI Direct Link
→View more research publications.

BioNews Results for Lacrimal Duct Obstruction:
Success Rate and Cause of Failure for Late Probing for Congenital Nasolacrimal Duct Obstruction	PCON SuperSite:  Jun 6 2008 2:38PM Matching: lacrimal duct obstruction

Lacrimal Duct Obstruction Clinical Trials:
Endoscopic Dacryocystorhinostomy Prospective Research	Lacrimal Duct Obstruction

Lacrimal Duct Obstruction Patents:
US Patent No.	Title
7232667	Keratinocyte growth factor-2 polynucleotides
7129243	Peptide compounds
7060723	Treating neurological disorders using selective antagonists of persistent sodium current
6825200	Substituted dipeptides having nos inhibiting activity
6693077	Keratinocyte growth factor-2
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Lacrimal Duct Obstruction scientists - we have details of around 196 individuals working on Lacrimal Duct Obstruction .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.